ERBB2 and breast cancer: Conversely, a number of studies have demonstrated a high degree of concordance between classical IHC markers for breast cancer, namely oestrogen, progesterone and HER2 receptors24, 25 between diagnostic core and excision biopsies, suggesting discordance may be limited to the level of transcription.